Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Lonardo · SciRah

Researcher profile · Semantic Scholar

A. Lonardo

Share profile

A. Lonardo — researcher profile on SciRah

h-index: 71
Works: 369
Citations: 21K

Most-cited papers

Global burden of metabolic diseases, 1990-2021.
Huai Zhang, Xiao-Dong Zhou, M. D. Shapiro, G. Lip +52 more
2024Metabolism: Clinical and Experimental356 citations Open access
Semantic Scholar
Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021
Xiao-Dong Zhou, Qin-Fen Chen, Wah Yang, Mauricio Zuluaga +47 more
2024EClinicalMedicine234 citations Open access
Semantic Scholar
Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers.
A. Mantovani, A. Lonardo, Norbert Stefan, G. Targher
2024Metabolism: Clinical and Experimental47 citations
Semantic Scholar
Global burden of disease attributable to metabolic risk factors in adolescents and young adults aged 15-39, 1990-2021.
Xiao-Dong Zhou, Qin-Fen Chen, G. Targher, Christopher D. Byrne +61 more
2024Clinical Nutrition47 citations Open access
Semantic Scholar
Sex and Gender Differences in Liver Fibrosis: Pathomechanisms and Clinical Outcomes
Mohamad Jamalinia, A. Lonardo, Ralf Weiskirchen
2024Fibrosis42 citations Open access
Semantic Scholar
Clinical Features and Long-Term Outcomes of Patients Diagnosed with MASLD, MAFLD, or Both.
Xiao-Dong Zhou, A. Lonardo, Calvin Q. Pan, Michael D. Shapiro +1 more
2024Journal of Hepatology36 citations
Semantic Scholar
Liver fibrosis in nonalcoholic fatty liver disease patients: noninvasive evaluation and correlation with cardiovascular disease and mortality
S. Ballestri, A. Mantovani, M. Di Girolamo, E. Baldelli +2 more
2023Metabolism and Target Organ Damage35 citations Open access
Semantic Scholar
Sex Hormones and Metabolic Dysfunction-Associated Steatotic Liver Disease
Ralf Weiskirchen, A. Lonardo
2025International Journal of Molecular Sciences34 citations Open access
Semantic Scholar
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
Huai Zhang, G. Targher, Christopher D. Byrne, S. Kim +90 more
2024Hepatology International34 citations Open access
Semantic Scholar
Researchers call for more flexible editorial conduct rather than abruptly adopting only the new MASLD nomenclature.
A. Lonardo, F. Bril, Stephen H. Caldwell, M. Eslam +11 more
2024Journal of Hepatology33 citations Open access
Semantic Scholar
Endpoints in NASH Clinical Trials: Are We Blind in One Eye?
A. Lonardo, S. Ballestri, A. Mantovani, G. Targher +1 more
2024Metabolites32 citations Open access
Semantic Scholar
Association of NAFLD/NASH, and MAFLD/MASLD with chronic kidney disease: an updated narrative review
A. Lonardo
2024Metabolism and Target Organ Damage32 citations Open access
Semantic Scholar
Liver fibrosis as a barometer of systemic health by gauging the risk of extrahepatic disease
A. Lonardo, S. Ballestri, Gyorgy Baffy, Ralf Weiskirchen
2024Metabolism and Target Organ Damage31 citations Open access
Semantic Scholar
Insulin Resistance at the Crossroads of Metabolic Inflammation, Cardiovascular Disease, Organ Failure and Cancer
A. Lonardo, Ralf Weiskirchen
2025Biomolecules29 citations Open access
Semantic Scholar
Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases
Norbert Stefan, A. Lonardo, G. Targher
2023Nature reviews: Gastroenterology & hepatology29 citations
Semantic Scholar
Metabolic primary liver cancer in adults: risk factors and pathogenic mechanisms
S. Lugari, E. Baldelli, A. Lonardo
2023Metabolism and Target Organ Damage29 citations Open access
Semantic Scholar
The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiers
A. Lonardo
2023Expert Review of Clinical Pharmacology25 citations
Semantic Scholar
Global, regional, and national burden of primary liver cancer attributable to metabolic risks: an analysis of the Global Burden of Disease Study 1990-2021.
Chu-Tian Wu, G. Targher, Christopher D. Byrne, Yi-Lei Mao +43 more
2025American Journal of Gastroenterology24 citations
Semantic Scholar
How ‘miracle’ weight‐loss semaglutide promises to change medicine but can we afford the expense?
Ralf Weiskirchen, A. Lonardo
2025British Journal of Pharmacology23 citations Open access
Semantic Scholar
The Ovary–Liver Axis: Molecular Science and Epidemiology
Ralf Weiskirchen, A. Lonardo
2025International Journal of Molecular Sciences21 citations Open access
Semantic Scholar
Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge
Mohamad Jamalinia, A. Lonardo
2024Metabolism and Target Organ Damage21 citations Open access
Semantic Scholar
Widening research horizons on metabolic dysfunction-associated steatotic liver disease and cancer.
A. Lonardo, Norbert Stefan, A. Mantovani
2025Trends in endocrinology and metabolism20 citations
Semantic Scholar
PNPLA3 as a driver of steatotic liver disease: navigating from pathobiology to the clinics via epidemiology
Ralf Weiskirchen, A. Lonardo
2024Journal of Translational Genetics and Genomics20 citations Open access
Semantic Scholar
Liver and obesity: a narrative review
A. Lonardo, Ralf Weiskirchen
2025Exploration of Medicine19 citations Open access
Semantic Scholar
Alanine aminotransferase predicts incident steatotic liver disease of metabolic etiology: Long life to the old biomarker!
A. Lonardo
2024World Journal of Gastroenterology18 citations Open access
Semantic Scholar
Erratum: Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021.
Xiao-Dong Zhou, Qin-Fen Chen, Wah Yang, Mauricio Zuluaga +47 more
2024EClinicalMedicine17 citations Open access
Semantic Scholar
Liver-Kidney-Metabolic Health, Sex, and Menopause Impact Total Scores and Monovessel vs. Multivessel Coronary Artery Calcification
K. Bagheri Lankarani, Mohamad Jamalinia, Fatemeh Zare, S. Heydari +2 more
2025Advances in Therapy16 citations
Semantic Scholar
Biological determinants and outcomes of sex discrepancies in MASLD
A. Lonardo, Mohamad Jamalinia, Ralf Weiskirchen
2026Metabolism and Target Organ Damage14 citations Open access
Semantic Scholar
Burden of metabolic diseases, 1990-2023, with forecasts to 2030 for the Asia-Pacific region.
Huai Zhang, Qin-Fen Chen, G. Y. H. Lip, Herbert Tilg +13 more
2026Metabolism: Clinical and Experimental13 citations
Semantic Scholar
Semaglutide from Bench to Bedside: The Experimental Journey Towards a Transformative Therapy for Diabetes, Obesity and Metabolic Liver Disorders
Ralf Weiskirchen, A. Lonardo
2025Medical Science13 citations Open access
Semantic Scholar
Food insecurity is an emerging risk factor for liver disease: a scoping review
A. Lonardo, M. Zheng, Ralf Weiskirchen
2025Expert Review of Gastroenterology & Hepatology13 citations
Semantic Scholar
Dual etiology vs. MetALD: how MAFLD and MASLD address liver diseases coexistence
Shadi Zerehpooshnesfchi, A. Lonardo, Jian-Gao Fan, Reda Elwakil +4 more
2025Metabolism and Target Organ Damage10 citations Open access
Semantic Scholar
Extra-hepatic cancers in metabolic fatty liver syndromes
A. Lonardo
2023Exploration of Digestive Diseases10 citations Open access
Semantic Scholar
From Hypothalamic Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease: Physiology Meets the Clinics via Metabolomics
A. Lonardo, Ralf Weiskirchen
2024Metabolites9 citations Open access
Semantic Scholar
Sex differences in alcohol-related liver disease, viral hepatitis, metabolic dysfunction-associated steatotic liver disease, and hepatocellular carcinoma
A. Lonardo, Ayako Suzuki
2025Exploration of Digestive Diseases8 citations Open access
Semantic Scholar
Liver Fibrosis and Risk of Incident Dementia in the General Population: Systematic Review With Meta‐Analysis
Mohamad Jamalinia, Fatemeh Zare, A. Lonardo
2025Health Science Reports8 citations Open access
Semantic Scholar
Resmetirom: Finally, the Light at the End of the NASH Tunnel?
A. Lonardo
2024Livers8 citations Open access
Semantic Scholar
Ultrasonographic fatty liver indicator (US-FLI): a reliable biomarker for non-invasive NAFLD stratification
S. Ballestri, A. Lonardo
2023Metabolism and Target Organ Damage8 citations Open access
Semantic Scholar
Lipid droplet dynamics in metabolic regulation
Ralf Weiskirchen, S. Weiskirchen, A. Lonardo
2026RSC Chemical Biology7 citations Open access
Semantic Scholar
Colorectal cancer in metabolic dysfunction-associated steatotic liver disease: an international Delphi consensus statement
Chu-Tian Wu, G. Targher, Christopher D. Byrne, Z. Younossi +32 more
2026Gut7 citations Open access
Semantic Scholar
The global burden of diabetes-related chronic kidney disease from 1990 to 2021, with projections to 2036
Wen-Yue Liu, Wen-Ying Chen, Jia-Hui Zhang, G. Targher +5 more
2025Metabolism and Target Organ Damage7 citations Open access
Semantic Scholar
MASLD: predictive value for liver-related events and extra-hepatic complications
Mohamad Jamalinia, A. Lonardo
2024Expert Review of Gastroenterology & Hepatology7 citations
Semantic Scholar
Principles of risk stratification in nonalcoholic fatty liver disease. A narrative review emphasizing non-invasive strategies
A. Lonardo
2023Exploration of Digestive Diseases7 citations Open access
Semantic Scholar
Duodenal mucosa resurfacing: the endoscopic silver bullet against metabolic disorders?
A. Lonardo, A. Singal
2025Metabolism and Target Organ Damage6 citations Open access
Semantic Scholar
Tirzepatide in metabolic dysfunction-associated steatotic liver disease and steatohepatitis: a novel star on the horizon?
A. Lonardo, Ralf Weiskirchen
2025Exploration of Drug Science6 citations Open access
Semantic Scholar
PPARs in molecular pathogenesis and drug treatment of type 2 diabetes-related MASLD
A. Lonardo, Ralf Weiskirchen
2025Exploration of Digestive Diseases6 citations Open access
Semantic Scholar
Copper and liver fibrosis in MASLD: the two-edged sword of copper deficiency and toxicity
A. Lonardo, Ralf Weiskirchen
2024Metabolism and Target Organ Damage6 citations Open access
Semantic Scholar
Commentary: Of women, liver, and heart
Jun Wang, A. Lonardo
2023Metabolism and Target Organ Damage6 citations Open access
Semantic Scholar
Obesity, Metabolic Dysfunction-Associated Steatotic Liver Disease and Hepatocellular Carcinoma: How Molecular Changes Impact Cellular Functions
Ralf Weiskirchen, A. Lonardo
2026Biocell (Mendoza)5 citations Open access
Semantic Scholar
Relevance of lipid droplets in metabolic dysfunction-associated steatotic liver disease
Ralf Weiskirchen, A. Lonardo
2026Expert opinion on therapeutic targets5 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Ralf Weiskirchen×16
Invite
Ralf Weiskirchen — researcher profile on SciRah
G. Targher×11
Invite
G. Targher — researcher profile on SciRah
S. Sookoian×7
Invite
S. Sookoian — researcher profile on SciRah
Xiao-Dong Zhou×6
Invite
Xiao-Dong Zhou — researcher profile on SciRah

×6

Invite

Nilanka Perera — researcher profile on SciRah

Invite

Anoop Misra — researcher profile on SciRah

S. Treeprasertsuk×6

Invite

S. Treeprasertsuk — researcher profile on SciRah

Invite

P. Ocama — researcher profile on SciRah

Invite

K. Alswat — researcher profile on SciRah

Yasser M. Fouad×6

Invite

Yasser M. Fouad — researcher profile on SciRah

Invite

M. Zheng — researcher profile on SciRah

Mohamad Jamalinia×6

Invite

Mohamad Jamalinia — researcher profile on SciRah